04 February, 2014

Radisson Blu Hotel, London

Thought Leadership

Chemical Supply Chain Content

Procurement Knowledge Portal

BioBusiness 2012 - The leading high-level BioPharma strategy and bio-partnering conference

View the agenda

Contact us with any questions

Reserve your seat

What attendees said about BioBusiness 2012

"Audience interaction was great – like the debate!" - Carole Nuechterlein, Roche Holding AG

"Small meeting with opportunity to meet others informally" – Rob Pinnock, Merck & Co. Inc

"Location and senior level attendees" - Malcolm Bates, Taylor Wessing LLP

"Gain insight from investors, big pharma and biotech peers. Meet potential partners. Difference is intimacy" – Rob Grundy, Almac Discovery Ltd

"Quality of attendees, timing, difference to other meetings." - N.J McWilliam, Flamel Technologies

BioBusiness - the leading bio-partnering life science conference which places strategy at its core

BioBusiness 2014 will be the only place in London where senior professionals, VP to CEO level delegates from small biotech's through to top 10 pharma's and key financers and advisors behind innovation will gather to discuss high level strategy and build quality relationships. This event is where forward thinking companies will come to make their next big deal.

Why BioBusiness is Different from other European bio-partnering conferences

BioBusiness isn't your typical frenzied partnering meeting with a huge exhibition, covering everything under the sun; only the most pertinent issues having an impact on your strategies will be discussed. Most importantly, the real decision makers will be there, and you'll have quality, face-to-face time with people that matter.

post-it-pharmaExec

post-it-bioExec

post-it-financing

Request the conference programme

Find out more about prices

Request a call back

BioBusiness 2012 offered:

cheack

300 + VP to CEO level delegates

cheack

65+ industry thought-leaders

cheack

30+ sessions

cheack

6+ off-the-record case studies and deal analyses

cheack

ONE EVENTwith key decision makers in one place in London

Speakers at BioBusiness 2012 included:

PharmaBiotech CEOsVenture Funds

Pharma

Speakers

/uploadedImages/Events/UK/2012/10978_006/Event_Details/speaker_photos/Joseph McCracken - Roche.jpg

Joseph McCracken

Global Head for Business Development & Licensing, Roche

SG1

Shaun Grady

Vice President - Strategic Partnering & Business Development, AstraZeneca

Steven Holtzman

Executive Vice President, Corporate Development, Biogen Idec

John Adamou

Head, Strategic Transactions & Alliance Management, Boehringer Ingelheim

How 2012 differed from 2011

BioBusiness is:

More Value for Money:

Over twice as much content as 2011 over three packed days
Almost double the number of speakers - 65+ thought-leaders
Multiple streams – customise and prioritise your conference agenda

More Senior & Strategic:

Forward looking content tackling issues that matter
Senior advisory panel directing the agenda
Pharma VPs – EVPs, CEOs from Biotech and Partner – CEOs from VCs speaking

More International, Less Parochial:

Over 30% of our speakers from beyond Europe to the US and Asia
Brand new speakers and industry titans
Issues affecting the global biopharma community

Issues that matter to you:

Early stage funding
R&D efficiency and externalisation
Payer's perspectives
Corporate venture capital trends
Deal structures and trends
Alliance management
Outlicensing, divestment and spinouts

Find out why BioBusiness is unique